Skip to main content

Masao Kakoki, MD, PhD

Associate Professor

Research Interests

My research aims at prevention and treatment of cardiovascular/renal diseases and focuses on the identification of genes that confer susceptibility or resistance to the diseases with the use of genetically engineered mice.

Selected Publications

1. Hathaway CK, Gasim AMH, Grant R, Xu L, Chang AS, Kim HS, Madden VJ, Bagnell CR Jr., Jennette JC, Smithies O, Kakoki, M. Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice. Proc Natl Acad Sci U S A. 2015; 112(18):5815-20.

2. Hathaway CK, Grant R, Hagaman JR, Hiller SK, Li F, Xu L, Chang AS, Madden VJ, Bagnell CR Jr., Rojas M, Kim HS, Wu B, Zhou B, Smithies O, Kakoki, M. Endothelin-1 critically influences cardiac function via superoxide-MMP9 cascade. Proc Natl Acad Sci U S A. 2015; 112(16):5141-6.

3. Bai X, Lenhart KC, Bird KE, Suen AA, Rojas M, Kakoki M, Li F, Smithies O, Mack CP, Taylor JM. The smooth muscle-selective RhoGAP GRAF3 is a critical regulator of vascular tone and hypertension. Nat Commun. 2013;4:2910. doi: 10.1038/ncomms3910.

4. Kakoki M, Pochynyuk OM, Hathaway CM, Tomita H, Hagaman JR, Kim HS, Zaika OL, Mamenko M, Kayashima Y, Matsuki K, Hiller S, Li F, Xu L, Grant R, Bertorello AM, Smithies O. Primary aldosteronism and impaired natriuresis in mice underexpressing TGFβ1. Proc Natl Acad Sci U S A. 2013; 110(14):5600-5.

5. Vashistha H, Singhal PC, Malhotra A, Husain M, Mathieson P, Saleem MA, Kuriakose C, Seshan S, Wilk A, Delvalle L, Peruzzi F, Giorgio M, Pelicci PG, Smithies O, Kim HS, Kakoki M, Reiss K, Meggs LG. Null mutations at the p66 and bradykinin 2 receptor loci induce divergent phenotypes in the diabetic kidney. Am J Physiol Renal Physiol. 2012; 303:F1629-40.

6. Kakoki, M., Sullivan, K.A., Backus, C., Hayes, J.M., Oh, S.S., Hua, K., Gasim, A.M., Tomita, H., Grant, R., Nossov, S.B., Kim, H.S., Jennette, J.C., Feldman, E.L., Smithies, O. Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice. Proc. Natl. Acad. Sci. U. S. A. 2010;107:10190-5.

7. Wende, A.R., Soto, J., Olsen, C.D., Pires, K.M., Schell, J.C., Larrieu-Lahargue, F., Litwin, S.E., Kakoki, M., Takahashi, N., Smithies, O., Abel, E.D. Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice. Endocrinology 2010;151:3536-3542.

8. Brosius, F.C.,3rd, Alpers, C.E., Bottinger, E.P., Breyer, M.D., Coffman, T.M., Gurley, S.B., Harris, R.C., Kakoki, M., Kretzler, M., Leiter, E.H., Levi, M., McIndoe, R.A., Sharma, K., Smithies, O., Susztak, K., Takahashi, N., Takahashi, T. Mouse models of diabetic nephropathy. J. Am. Soc. Nephrol. 2009;20:2503-2512.

9. Kakoki, M., and Smithies, O. The kallikrein-kinin system in health and in diseases of the kidney. Kidney Int. 2009;75:1019-1030.

10. Kakoki, M., Tsai, Y.S., Kim, H.S., Hatada, S., Ciavatta, D.J., Takahashi, N., Arnold, L.W., Maeda, N., Smithies, O. Altering the expression in mice of genes by modifying their 3′ regions. Dev. Cell. 2004;6:597-606.

List of publications from PubMed

Masao Kakoki